StockData
TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31

Tiziana Life Sciences Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 1, 2026
$1.01−0.04 (-3.81%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Tiziana Life Sciences's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
5 buys · 0 sales
Net bought $1.04M

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Laura Natalia Monica Fonda6,805,5565.70%13G (passive)Sep 12, 2025
Chernett Jorey6,476,4715.40%13G (passive) amendmentSep 30, 2025

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ivor ElrifiChief Executive Officer9,648,9458.01%Sep 29, 2026
Keeren Rameshchandra ShahCHIEF OPERATING & FIN. OFFICER2,5000.00%May 22, 2026
Gabriele M. CerroneDirector, 10% owner89,469,41774.24%Aug 7, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ivor Elrifi
Chief Executive Officer
Aug 15, 2026Option exercise+1,050,000––5,843,684
Ivor Elrifi
Chief Executive Officer
Aug 5, 2026Buy+237,616$1.00$237.62K4,793,684
Ivor Elrifi
Chief Executive Officer
Aug 4, 2026Buy+83,807$0.97$81.29K4,556,068
Ivor Elrifi
Chief Executive Officer
Aug 3, 2026Buy+667,000$1.00$667.00K4,472,261
Gabriele M. Cerrone
Director, 10% owner
Jul 21, 2026Buy+42,357$0.99$41.93K44,814,587
Gabriele M. Cerrone
Director, 10% owner
Jul 21, 2026Award+42,357$0.99$41.93K44,814,587
Gabriele M. Cerrone
Director, 10% owner
Jun 12, 2026Buy+15,000$1.11$16.65K44,772,230
Gabriele M. Cerrone
Director, 10% owner
Jun 12, 2026Award+15,000$1.11$16.65K44,772,230

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.